- The trend backdrop is active with a 25-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Activity pressure is constructive, supporting the smart-money activity read.
GDS
PAR
Week ended 07 Aug 2026
Weekly Investor Report
Ramsay Générale de Santé SA · Healthcare · Medical Care Facilities
Latest close
10.90 EUR
-0.9%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 2.3% above the Trend Line and sits at 78.4% of its 52-week range. The latest completed week returned -0.9%, after a -2.7% four-week move. The latest news-sentiment score is 46/100. Near-term considerations: volume confirmation is below normal.
Setup score
51
out of 100
Latest Close
10.90 EUR
7 Aug 2026
1W Return
-0.9%
latest completed week
4W Return
-2.7%
short-term follow-through
12W Return
5.8%
quarterly tape
Trend Breadth
48.1%
25 of 52 weeks active
Volume Ratio
0.5x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 37.82% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.9%
Latest completed week; four-week move -2.7%.
Indicator stack
71/50
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 37.82%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
46/100
8 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 2.3% above the Trend Line and sits at 78.4% of its 52-week range. The latest completed week returned -0.9%, after a -2.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8012-week average 0.71
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.80Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -2.7% over four weeks, 5.8% over 12 weeks, and 7.4% over one year. The current trend has remained active for 25 consecutive weeks.
Performance by holding period
Active trend streak25 weeks
Active weeks in one year25
Trend breadth48.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.25Latest activity-pressure read.
Pressure change-56.3%Four-week change in activity pressure.
Leadership0.57Latest relative-leadership reading.
RS change-92.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment46/100
Weighted news tone is neutral across 8 relevant articles.
0 positive · 6 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-5.2%Distance below the 52-week high.
13-week volatility3.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2614 weeks finished lower.
Best week+8.0%Week of 29 May.
Worst week-4.4%Week of 27 Mar.
Latest week-0.9%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains8
Flat weeks1
Modest losses12
Sharp losses2
Recent vol3.2%13-week weekly-return volatility.
Base vol3.6%52-week weekly-return volatility.
Up/down split23/25Count of positive and negative weeks in the 52-week window.
Average skew3.2% / -2.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Healthcare
4-week rank49 / 76
Group average0.7%
Trend breadth26.3%
Trend26.3%active weekly trend signals
MD40.8%positive activity pressure
RS19.7%positive relative leadership
Four-week leaders
IndustryFR Medical Care Facilities
4-week rank4 / 4
Group average1.5%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD50.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape53/100
Trend, activity pressure, participation, and risk combine to a 53/100 tape read.
Indicator analysis83/100Latest 12-week confirmation: trend 12/12, activity pressure 9/12, relative leadership 12/12.
Activity pressure 0.80; No reversal markers Next-Week ExpectancyNegative 37.82%Next-week expectancy is negative with a 37.82% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment46/100Weighted news tone is neutral across 8 relevant articles.
Ramsay Santé refinances €1.75bn debt and prepares ASX CDI listing ahead of RHC demerger Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 10.90 EUR | -0.9% | 10.66 EUR | 13.08 EUR | 0.25 | 0.57 | 671 | On |
| 31 Jul 2026 | 11.00 EUR | 2.3% | 10.60 EUR | 13.14 EUR | 0.40 | 3.85 | 2.4K | On |
| 24 Jul 2026 | 10.75 EUR | -1.8% | 10.55 EUR | 13.21 EUR | 0.44 | 3.00 | 257 | On |
| 17 Jul 2026 | 10.95 EUR | -2.2% | 10.48 EUR | 13.28 EUR | 0.61 | 5.21 | 2.3K | On |
| 10 Jul 2026 | 11.20 EUR | 1.4% | 10.41 EUR | 13.35 EUR | 0.57 | 7.48 | 296 | On |
| 3 Jul 2026 | 11.05 EUR | -2.2% | 10.35 EUR | 13.41 EUR | 0.55 | 3.87 | 76 | On |
| 26 Jun 2026 | 11.30 EUR | 2.3% | 10.28 EUR | 13.47 EUR | 0.41 | 7.55 | 105 | On |
| 19 Jun 2026 | 11.05 EUR | -2.6% | 10.20 EUR | 13.53 EUR | 0.40 | 4.60 | 67 | On |
| 12 Jun 2026 | 11.35 EUR | 3.2% | 10.13 EUR | 13.59 EUR | 0.23 | 8.14 | 966 | On |
| 5 Jun 2026 | 11.00 EUR | -4.3% | 10.05 EUR | 13.64 EUR | -0.02 | 6.34 | 206 | On |
| 29 May 2026 | 11.50 EUR | 8.0% | 9.99 EUR | 13.70 EUR | -0.08 | 11.58 | 6.0K | On |
| 22 May 2026 | 10.65 EUR | 3.4% | 9.91 EUR | 13.75 EUR | -0.41 | 4.21 | 1.4K | On |
| 15 May 2026 | 10.30 EUR | -1.0% | 9.86 EUR | 13.81 EUR | -0.45 | 2.86 | 1.9K | On |
| 8 May 2026 | 10.40 EUR | 5.3% | 9.81 EUR | 13.87 EUR | -0.41 | 1.80 | 5.6K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.